These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

528 related items for PubMed ID: 15113324

  • 1. Methicillin-resistant Staphylococcus aureus (MRSA) with reduced susceptibility to glycopeptides (GISA) in 63 French general hospitals.
    Cartolano GL, Cheron M, Benabid D, Leneveu M, Boisivon A, Association of Hospital Bacteriologists, Virologists and Hygiene Professionals.
    Clin Microbiol Infect; 2004 May; 10(5):448-51. PubMed ID: 15113324
    [Abstract] [Full Text] [Related]

  • 2. Low prevalence of methicillin-resistant Staphylococcus aureus with reduced susceptibility to glycopeptides in Belgian hospitals.
    Nonhoff C, Denis O, Struelens MJ.
    Clin Microbiol Infect; 2005 Mar; 11(3):214-20. PubMed ID: 15715719
    [Abstract] [Full Text] [Related]

  • 3. Comparative analysis and validation of different assays for glycopeptide susceptibility among methicillin-resistant Staphylococcus aureus strains.
    Bernard L, Vaudaux P, Rohner P, Huggler E, Armanet M, Pittet D, Lew DP, Schrenzel J.
    J Microbiol Methods; 2004 May; 57(2):231-9. PubMed ID: 15063063
    [Abstract] [Full Text] [Related]

  • 4. Detection of an outbreak of methicillin-resistant Staphylococcus aureus with reduced susceptibility to glycopeptides in a French hospital.
    Mallaval FO, Carricajo A, Delavenna F, Recule C, Fonsale N, Manquat G, Raffenot D, Rogeaux O, Aubert G, Tous J.
    Clin Microbiol Infect; 2004 May; 10(5):459-61. PubMed ID: 15113326
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Investigation of reduced susceptibility to glycopeptides among methicillin-resistant Staphylococcus aureus isolates from patients in Ireland and evaluation of agar screening methods for detection of heterogeneously glycopeptide-intermediate S. aureus.
    Fitzgibbon MM, Rossney AS, O'Connell B.
    J Clin Microbiol; 2007 Oct; 45(10):3263-9. PubMed ID: 17687008
    [Abstract] [Full Text] [Related]

  • 9. [Searching for Staphylococcus aureus strains with reduced susceptibility to glycopeptides among clinical isolates obtained during the year of 2002].
    Młynarczyk A, Młynarczyk G, Łuczak M.
    Med Dosw Mikrobiol; 2003 Oct; 55(3):209-17. PubMed ID: 14702662
    [Abstract] [Full Text] [Related]

  • 10. Incidence of glycopeptide hetero-intermediate Staphylococcus aureus strains in Maltese hospitals.
    Borg MA, Zerafa R, Morrison D, Cuschieri P.
    Clin Microbiol Infect; 2005 May; 11(5):405-7. PubMed ID: 15819869
    [Abstract] [Full Text] [Related]

  • 11. Methicillin-resistant Staphylococcus aureus heterogeneously resistant to vancomycin in a Turkish university hospital.
    Sancak B, Ercis S, Menemenlioglu D, Colakoglu S, Hasçelik G.
    J Antimicrob Chemother; 2005 Sep; 56(3):519-23. PubMed ID: 16046461
    [Abstract] [Full Text] [Related]

  • 12. Decreased susceptibility to glycopeptides in methicillin-resistant Staphylococcus aureus: a 20 year study in a large French teaching hospital, 1983-2002.
    Robert J, Bismuth R, Jarlier V.
    J Antimicrob Chemother; 2006 Mar; 57(3):506-10. PubMed ID: 16410265
    [Abstract] [Full Text] [Related]

  • 13. Surveillance of antibacterial resistance in Staphylococcus aureus isolated in Kuwaiti hospitals.
    Udo EE, Al-Sweih N, Dhar R, Dimitrov TS, Mokaddas EM, Johny M, Al-Obaid IA, Gomaa HH, Mobasher LA, Rotimi VO, Al-Asar A.
    Med Princ Pract; 2008 Mar; 17(1):71-5. PubMed ID: 18059105
    [Abstract] [Full Text] [Related]

  • 14. Incidence of Staphylococcus aureus with reduced susceptibility to glycopeptides in two French hospitals.
    Reverdy ME, Jarraud S, Bobin-Dubreux S, Burel E, Girardo P, Lina G, Vandenesch F, Etienne J.
    Clin Microbiol Infect; 2001 May; 7(5):267-72. PubMed ID: 11422254
    [Abstract] [Full Text] [Related]

  • 15. [Investigation of glycopeptide resistance in methicillin resistant staphylococcal isolates].
    Hoşgör Limoncu M, Ermertcan S, Taşli H, Kurutepe S.
    Mikrobiyol Bul; 2007 Oct; 41(4):511-6. PubMed ID: 18173069
    [Abstract] [Full Text] [Related]

  • 16. Multilocus sequence typing (MLST) shows that the 'Iberian' clone of methicillin-resistant Staphylococcus aureus has spread to France and acquired reduced susceptibility to teicoplanin.
    Heym B, Le Moal M, Armand-Lefevre L, Nicolas-Chanoine MH.
    J Antimicrob Chemother; 2002 Sep; 50(3):323-9. PubMed ID: 12205056
    [Abstract] [Full Text] [Related]

  • 17. Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group.
    Smith TL, Pearson ML, Wilcox KR, Cruz C, Lancaster MV, Robinson-Dunn B, Tenover FC, Zervos MJ, Band JD, White E, Jarvis WR.
    N Engl J Med; 1999 Feb 18; 340(7):493-501. PubMed ID: 10021469
    [Abstract] [Full Text] [Related]

  • 18. Comparative activity of tedizolid and glycopeptide combination therapies for the treatment of Staphylococcus aureus infections: an in vitro and in vivo evaluation against strains with reduced susceptibility to glycopeptides.
    Betts JW, Abdul Momin HF, Phee LM, Wareham DW.
    J Med Microbiol; 2018 Feb 18; 67(2):265-271. PubMed ID: 29300156
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Glycopeptide-intermediate Staphylococcus aureus: evaluation of a novel screening method and results of a survey of selected U.S. hospitals.
    Hubert SK, Mohammed JM, Fridkin SK, Gaynes RP, McGowan JE, Tenover FC.
    J Clin Microbiol; 1999 Nov 18; 37(11):3590-3. PubMed ID: 10523558
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.